[1]
“EARLY DRUG THERAPY FOR FACIAL INFANTILE HEMANGIOMAS: A COMPARATIVE ANALYSIS”, ibmscr, vol. 5, no. 2, pp. 45–50, Feb. 2025, doi: 10.37547/.